The current status of oncolytic viral therapy for head and neck cancer

por Matthew O. Old, Trisha Wise-Draper, Chadwick L. Wright, Balveen Kaur, Theodoros Teknos
Publicado 2016

Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.

por Yangjin Kim, Hyun Geun Lee, Nina Dmitrieva, Junseok Kim, Balveen Kaur, Avner Friedman
Publicado 2014

An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma

por Bo Xu, Lei Tian, Jing Chen, Jing Wang, Rui Ma, Wenjuan Dong, Aimin Li, Jianying Zhang, E. Antonio Chiocca, Balveen Kaur, Mingye Feng, Michael A. Caligiuri, Jianhua Yu
Publicado 2021

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44

por Margaret Yeh, Yin-Ying Wang, Ji Young Yoo, Christina Oh, Yoshihiro Otani, Jin Muk Kang, Eun S. Park, Eunhee Kim, Sangwoon Chung, Young-Jun Jeon, George A. Calin, Balveen Kaur, Zhongming Zhao, Tae Jin Lee
Publicado 2021

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance

por Luke Russell, Jessica Swanner, Alena Cristina Jaime-Ramirez, Yufeng Wang, Alex Sprague, Yeshavanth Banasavadi-Siddegowda, Ji Young Yoo, Gina M. Sizemore, Raleigh Kladney, Jianying Zhang, Norman L. Lehman, Michael C Ostrowski, Bangxing Hong, Michael Caligiuri, Jianhua Yu, Balveen Kaur
Publicado 2018